← Back to Clinical Trials
Recruiting NCT06682949

NCT06682949 Daily Routines, Executive Functioning & ADHD

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06682949
Status Recruiting
Phase
Sponsor Cori Manning
Condition Attention Deficit Disorder with Hyperactivity (ADHD)
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2024-11-04
Primary Completion 2025-05-01

Eligibility & Interventions

Sex All sexes
Min Age 11 Years
Max Age 17 Years
Study Type INTERVENTIONAL
Interventions
Sleep ExtensionDaytime Routine

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2024-11-04 with a primary completion date of 2025-05-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The goal of this clinical trial is to learn adjusting daily or nightly routines improves executive functioning in youth with ADHD. It will also learn about the acceptability of the intervention. The main questions it aims to answer are: 1. Does the intervention improve sleep for youth with ADHD? 2. Does the intervention improve areas of executive functioning for youth with ADHD? 3. Is this an acceptable intervention for youth with ADHD? Researchers will compare the two intervention conditions to see if their are impacts in executive functioning and sleep. Participants will: Complete cognitive testing, executive function tasks, questionnaires, and an interview at baseline and at one month Wear an actigraph watch for one month Bring a parent with them to three meetings Complete daily sleep diaries for one month

Eligibility Criteria

Inclusion Criteria: * Clinical diagnosis of attention-deficit/hyperactivity disorder (ADHD) * Located in the greater Tucson, AZ area * Must have a guardian willing to participate Exclusion Criteria: * Clinical diagnosis of autism spectrum disorder * Clinical diagnosis of an intellectual disability * Clinical diagnosis of psychosis * Clinical diagnosis of bipolar disorder

Contact & Investigator

Central Contact

Cori Manning, MA

✉ adhddailyroutines@gmail.com

📞 520-222-9047

Principal Investigator

Michelle Perfect, PhD

STUDY CHAIR

University of Arizona

Frequently Asked Questions

Who can join the NCT06682949 clinical trial?

This trial is open to participants of all sexes, aged 11 Years or older, up to 17 Years, studying Attention Deficit Disorder with Hyperactivity (ADHD). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06682949 currently recruiting?

Yes, NCT06682949 is actively recruiting participants. Contact the research team at adhddailyroutines@gmail.com for enrollment information.

Where is the NCT06682949 trial being conducted?

This trial is being conducted at Tucson, United States.

Who is sponsoring the NCT06682949 clinical trial?

NCT06682949 is sponsored by Cori Manning. The principal investigator is Michelle Perfect, PhD at University of Arizona. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology